Singapore now has an integrated translational R&D hub, supporting clinical diagnostics in collaboration between the National University of Singapore (NUS), Agilent Technologies and National University Hospital (NUH). The S$38 million research facility — named NUS-Agilent Hub — will develop new diagnostic tools to detect existing conditions in patients and test for indicators of other diseases for early prevention.
Subscribe to the Market Information Package (MIP)
A MIP subscription is required to access this content.
The MIP provides opportunities, market insights, and data to support Australia's international education and training sector.
Find out more about the MIP, eligibility and fees